Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing

Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and targets for therapy. Co-deletion of chromosomes 1p and 19q marks gliomas with an oligodendroglioma component and predicts a better prognosis and...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of molecular diagnostics : JMD Vol. 18; no. 5; pp. 775 - 786
Main Authors Dubbink, Hendrikus J., Atmodimedjo, Peggy N., van Marion, Ronald, Krol, Niels M.G., Riegman, Peter H.J., Kros, Johan M., van den Bent, Martin J., Dinjens, Winand N.M.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.09.2016
Subjects
Online AccessGet full text
ISSN1525-1578
1943-7811
DOI10.1016/j.jmoldx.2016.06.002

Cover

Abstract Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and targets for therapy. Co-deletion of chromosomes 1p and 19q marks gliomas with an oligodendroglioma component and predicts a better prognosis and response to chemotherapy. In the current study, we present a novel method to detect chromosome 1p/19q co-deletion or loss of heterozygosity (LOH) in a diagnostic setting, based on single-nucleotide polymorphism (SNP) analysis and next-generation sequencing (NGS). We selected highly polymorphic SNPs distributed evenly over both chromosome arms. To experimentally determine the sensitivity and specificity of targeted SNP analysis, we used DNAs extracted from 49 routine formalin-fixed, paraffin-embedded glioma tissues and compared the outcome with diagnostic microsatellite-based LOH analysis and calculated estimates. We show that targeted SNP analysis by NGS allows reliable detection of 1p and/or 19q deletion in a background of 70% of normal cells according to calculated outcomes, is more sensitive than microsatellite-based LOH analysis, and requires much less DNA. This specific and sensitive SNP assay is broadly applicable for simultaneous allelic imbalance analysis of multiple genomic regions and can be incorporated easily into NGS mutation analyses. The combined mutation and chromosomal imbalance analysis in a single NGS assay is suited perfectly for routine glioma diagnostics and other diagnostic molecular pathology applications.
AbstractList Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and targets for therapy. Co-deletion of chromosomes 1p and 19q marks gliomas with an oligodendroglioma component and predicts a better prognosis and response to chemotherapy. In the current study, we present a novel method to detect chromosome 1p/19q co-deletion or loss of heterozygosity (LOH) in a diagnostic setting, based on single-nucleotide polymorphism (SNP) analysis and next-generation sequencing (NGS). We selected highly polymorphic SNPs distributed evenly over both chromosome arms. To experimentally determine the sensitivity and specificity of targeted SNP analysis, we used DNAs extracted from 49 routine formalin-fixed, paraffin-embedded glioma tissues and compared the outcome with diagnostic microsatellite-based LOH analysis and calculated estimates. We show that targeted SNP analysis by NGS allows reliable detection of 1p and/or 19q deletion in a background of 70% of normal cells according to calculated outcomes, is more sensitive than microsatellite-based LOH analysis, and requires much less DNA. This specific and sensitive SNP assay is broadly applicable for simultaneous allelic imbalance analysis of multiple genomic regions and can be incorporated easily into NGS mutation analyses. The combined mutation and chromosomal imbalance analysis in a single NGS assay is suited perfectly for routine glioma diagnostics and other diagnostic molecular pathology applications.
Author Krol, Niels M.G.
van Marion, Ronald
Atmodimedjo, Peggy N.
Dinjens, Winand N.M.
van den Bent, Martin J.
Dubbink, Hendrikus J.
Riegman, Peter H.J.
Kros, Johan M.
Author_xml – sequence: 1
  givenname: Hendrikus J.
  surname: Dubbink
  fullname: Dubbink, Hendrikus J.
  email: h.dubbink@erasmusmc.nl
  organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
– sequence: 2
  givenname: Peggy N.
  surname: Atmodimedjo
  fullname: Atmodimedjo, Peggy N.
  organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
– sequence: 3
  givenname: Ronald
  surname: van Marion
  fullname: van Marion, Ronald
  organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
– sequence: 4
  givenname: Niels M.G.
  surname: Krol
  fullname: Krol, Niels M.G.
  organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
– sequence: 5
  givenname: Peter H.J.
  surname: Riegman
  fullname: Riegman, Peter H.J.
  organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
– sequence: 6
  givenname: Johan M.
  surname: Kros
  fullname: Kros, Johan M.
  organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
– sequence: 7
  givenname: Martin J.
  surname: van den Bent
  fullname: van den Bent, Martin J.
  organization: Department of Neuro-Oncology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
– sequence: 8
  givenname: Winand N.M.
  surname: Dinjens
  fullname: Dinjens, Winand N.M.
  organization: Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands
BookMark eNqVUdtKAzEQDaKgVf_Ah_2BrbltdldEEC-1UPSh-hyyybRkTbOarNL-vVnrkyBFGMhMhnNmzpkR2vedB4TOCB4TTMR5O25XnTPrMU3VGKfAdA8dkZqzvKwI2U95QYucFGV1iEYxthgTzgU9QvNbq5a-i73V2S30oHvb-axbZNfOgUufsy5GiJnyJpuuGuWU16lsNtkjrPt8Ah6C-sbM4f0DvLZ-eYIOFspFOP15j9HL_d3zzUM-e5pMb65nuWa0oHlhKgGNZjUxTY2poIUpDAdoyoLXwhCNmarKmuumoqIUuuSM1VqlvhKEAWPH6GLLq0NaMsBCatt_L9MHZZ0kWA72yFZu7ZGDPRKnwDSB-S_wW7ArFTa7YFdbGCRhnxaCjNom2WBsSOZJ09n_EmhnvdXKvcIGYtt9BJ9Mk0RGKrGcD4cb7kYEw7jGg-rLvwl2z_8CX5qtCw
CitedBy_id crossref_primary_10_1016_j_jmoldx_2021_06_004
crossref_primary_10_1158_1078_0432_CCR_21_4283
crossref_primary_10_1136_gutjnl_2016_312608
crossref_primary_10_1016_j_jmoldx_2017_11_011
crossref_primary_10_1002_mgg3_699
crossref_primary_10_1002_ijc_33327
crossref_primary_10_1007_s11060_018_2867_8
crossref_primary_10_1007_s12282_021_01276_3
crossref_primary_10_1016_j_yexmp_2024_104920
crossref_primary_10_1177_17562848211002023
crossref_primary_10_1093_neuonc_noab088
crossref_primary_10_1016_j_humpath_2022_05_001
crossref_primary_10_1093_neuonc_now277
crossref_primary_10_1111_apm_12916
crossref_primary_10_1016_S1470_2045_21_00090_5
crossref_primary_10_1093_neuonc_nox086
crossref_primary_10_1186_s40478_018_0633_y
crossref_primary_10_3389_fonc_2021_683057
crossref_primary_10_1111_neup_12672
crossref_primary_10_1158_1078_0432_CCR_19_1127
crossref_primary_10_1016_j_anndiagpath_2022_151899
crossref_primary_10_1007_s00428_019_02555_3
crossref_primary_10_1016_j_ibneur_2022_09_005
crossref_primary_10_1093_noajnl_vdaa109
crossref_primary_10_1097_PAP_0000000000000186
crossref_primary_10_1002_ijc_33853
crossref_primary_10_1002_cjp2_216
crossref_primary_10_5858_arpa_2021_0295_CP
crossref_primary_10_1093_jnen_nlae011
crossref_primary_10_4103_glioma_glioma_29_19
crossref_primary_10_1007_s00428_022_03268_w
crossref_primary_10_1007_s00401_017_1781_z
crossref_primary_10_1111_nan_12790
crossref_primary_10_3390_cells8101186
crossref_primary_10_1177_2374289518766521
crossref_primary_10_1186_s40478_022_01466_w
crossref_primary_10_1093_neuonc_nox176
crossref_primary_10_1016_j_ygyno_2019_03_003
crossref_primary_10_1097_PAP_0000000000000194
crossref_primary_10_1016_j_yexmp_2021_104621
crossref_primary_10_1080_02688697_2020_1847249
crossref_primary_10_5858_arpa_2019_0010_OA
crossref_primary_10_1002_14651858_CD013387_pub2
crossref_primary_10_1134_S1022795419090023
crossref_primary_10_1093_neuonc_noz200
crossref_primary_10_1016_j_ejmg_2020_103840
crossref_primary_10_1016_j_humpath_2017_05_005
crossref_primary_10_18632_oncotarget_19103
crossref_primary_10_1093_nop_npy041
crossref_primary_10_1016_j_jmoldx_2016_08_002
crossref_primary_10_1016_S0140_6736_17_31442_3
crossref_primary_10_1093_noajnl_vdaa009
crossref_primary_10_3390_cancers11060773
crossref_primary_10_1016_j_ejca_2022_12_010
crossref_primary_10_1093_neuonc_noy048
crossref_primary_10_1002_mgg3_2098
crossref_primary_10_1007_s11060_024_04563_z
crossref_primary_10_1038_modpathol_2017_187
crossref_primary_10_1186_s13104_017_2456_5
crossref_primary_10_3389_fonc_2022_861078
crossref_primary_10_5812_ans_68874
crossref_primary_10_3390_life12070956
Cites_doi 10.1158/0008-5472.CAN-06-1796
10.1016/j.jmoldx.2014.09.008
10.1186/gb-2010-11-8-r86
10.1093/nar/gkq603
10.1002/path.4419
10.1101/gr.4086505
10.1200/JCO.2005.04.6078
10.1053/j.gastro.2014.08.041
10.1093/neuonc/nov182
10.1111/j.1582-4934.2009.00977.x
10.1056/NEJMoa052306
10.1200/JCO.2005.04.3414
10.1097/01.LAB.0000059948.67795.EF
10.1016/j.molonc.2014.03.004
10.1053/j.gastro.2013.12.002
10.1200/JCO.2012.43.2229
10.1016/j.jmoldx.2013.08.004
10.1093/neuonc/nop075
10.2353/jmoldx.2006.060012
10.1016/j.jmoldx.2011.05.009
10.5858/2010-0649-RAIR.1
10.5414/NPP30047
10.1038/nbt.2696
10.1093/bioinformatics/btu436
10.1016/j.jmoldx.2013.03.001
10.1016/j.jmoldx.2014.12.006
10.1200/JCO.2009.24.1034
ContentType Journal Article
Copyright 2016 American Society for Investigative Pathology and the Association for Molecular Pathology
American Society for Investigative Pathology and the Association for Molecular Pathology
Copyright_xml – notice: 2016 American Society for Investigative Pathology and the Association for Molecular Pathology
– notice: American Society for Investigative Pathology and the Association for Molecular Pathology
DBID AAYXX
CITATION
DOI 10.1016/j.jmoldx.2016.06.002
DatabaseName CrossRef
DatabaseTitle CrossRef
DatabaseTitleList


DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1943-7811
EndPage 786
ExternalDocumentID 10_1016_j_jmoldx_2016_06_002
S1525157816300903
1_s2_0_S1525157816300903
GroupedDBID ---
--K
.1-
.55
.FO
.GJ
0R~
18M
1KJ
1P~
29L
2WC
34G
39C
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
AAEDT
AAEDW
AAIKJ
AALRI
AAQFI
AAQXK
AAXUO
AAYWO
ABJNI
ABLJU
ABMAC
ABOCM
ABWVN
ACGFS
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADHJS
ADMUD
ADNMO
ADVLN
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AGCQF
AGHFR
AGQPQ
AI.
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BAWUL
BELOY
CS3
DIK
DU5
E3Z
EBS
EFKBS
EJD
F5P
FDB
FEDTE
FGOYB
FRP
GBLVA
GX1
H13
HVGLF
HX~
HZ~
IH2
IXB
M41
O9-
OG0
OK1
OS0
P2P
R2-
ROL
SEL
SES
SJN
SSZ
TIP
TR2
VH1
WH7
WOQ
X7M
XH2
YHG
Z5R
ADPAM
AFCTW
NCXOZ
VXZ
AAIAV
AGZHU
AHPSJ
ALXNB
ZA5
AAYXX
CITATION
ID FETCH-LOGICAL-c3252-5d86ebc391db902625d5d4eeb75496d1c03a8794cb82676c74339caeb7a613e33
IEDL.DBID IXB
ISSN 1525-1578
IngestDate Tue Jul 01 04:02:34 EDT 2025
Thu Apr 24 22:52:31 EDT 2025
Fri Feb 23 02:31:44 EST 2024
Tue Feb 25 19:55:53 EST 2025
Tue Aug 26 16:34:00 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License This article is made available under the Elsevier license.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3252-5d86ebc391db902625d5d4eeb75496d1c03a8794cb82676c74339caeb7a613e33
OpenAccessLink https://www.clinicalkey.com/#!/content/1-s2.0-S1525157816300903
PageCount 12
ParticipantIDs crossref_citationtrail_10_1016_j_jmoldx_2016_06_002
crossref_primary_10_1016_j_jmoldx_2016_06_002
elsevier_sciencedirect_doi_10_1016_j_jmoldx_2016_06_002
elsevier_clinicalkeyesjournals_1_s2_0_S1525157816300903
elsevier_clinicalkey_doi_10_1016_j_jmoldx_2016_06_002
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2016-09
PublicationDateYYYYMMDD 2016-09-01
PublicationDate_xml – month: 09
  year: 2016
  text: 2016-09
PublicationDecade 2010
PublicationTitle The Journal of molecular diagnostics : JMD
PublicationYear 2016
Publisher Elsevier Inc
Publisher_xml – name: Elsevier Inc
References van den Bent, Brandes, Taphoorn, Kros, Kouwenhoven, Delattre, Bernsen, Frenay, Tijssen, Grisold, Sipos, Enting, French, Dinjens, Vecht, Allgeier, Lacombe, Gorlia, Hoang-Xuan (bib8) 2013; 31
Hatanpaa, Burger, Eshleman, Murphy, Berg (bib10) 2003; 83
Geurts-Giele, Leenen, Dubbink, Meijssen, Post, Sleddens, Kuipers, Goverde, van den Ouweland, van Lier, Steyerberg, van Leerdam, Wagner, Dinjens (bib24) 2014; 234
Harada, Henderson, Eshleman, Gocke, Burger, Griffin, Batista (bib12) 2011; 13
Piccart-Gebhart, Procter, Leyland-Jones, Goldhirsch, Untch, Smith, Gianni, Baselga, Bell, Jackisch, Cameron, Dowsett, Barrios, Steger, Huang, Andersson, Inbar, Lichinitser, Lang, Nitz, Iwata, Thomssen, Lohrisch, Suter, Ruschoff, Suto, Greatorex, Ward, Straehle, McFadden, Dolci, Gelber (bib3) 2005; 353
Dubbink, Atmodimedjo, Kros, French, Sanson, Idbaih, Wesseling, Enting, Spliet, Tijssen, Dinjens, Gorlia, van den Bent (bib23) 2016; 18
Jenkins, Blair, Ballman, Giannini, Arusell, Law, Flynn, Passe, Felten, Brown, Shaw, Buckner (bib5) 2006; 66
Dubbink, Deans, Tops, van Kemenade, Koljenovic, van Krieken, Blokx, Dinjens, Groenen (bib1) 2014; 8
Vogazianou, Chan, Backlund, Pearson, Liu, Langford, Gregory, Collins, Ichimura (bib6) 2010; 12
Cairncross, Berkey, Shaw, Jenkins, Scheithauer, Brachman, Buckner, Fink, Souhami, Laperierre, Mehta, Curran (bib7) 2006; 24
Nikiforova, Hamilton (bib13) 2011; 135
van Lier, Wagner, van Leerdam, Biermann, Kuipers, Steyerberg, Dubbink, Dinjens (bib21) 2010; 14
Haraldsdottir, Hampel, Tomsic, Frankel, Pearlman, de la Chapelle, Pritchard (bib29) 2014; 147
Boeva, Popova, Lienard, Toffoli, Kamal, Le Tourneau, Gentien, Servant, Gestraud, Rio Frio, Hupe, Barillot, Laes (bib15) 2014; 30
Grasso, Butler, Rhodes, Quist, Neff, Moore, Tomlins, Reinig, Beadling, Andersen, Corless (bib17) 2015; 17
Mensenkamp, Vogelaar, van Zelst-Stams, Goossens, Ouchene, Hendriks-Cornelissen, Kwint, Hoogerbrugge, Nagtegaal, Ligtenberg (bib28) 2014; 146
(accessed July 25, 2016).
Federation of Medical Scientific Societies: Human tissue and medical research: code of conduct for responsible use (2011). Available at
Goecks, Nekrutenko, Taylor, Galaxy (bib26) 2010; 11
Cheng, Mitchell, Zehir, Shah, Benayed, Syed, Chandramohan, Liu, Won, Scott, Brannon, O'Reilly, Sadowska, Casanova, Yannes, Hechtman, Yao, Song, Ross, Oultache, Dogan, Borsu, Hameed, Nafa, Arcila, Ladanyi, Berger (bib18) 2015; 17
Wang, Li, Hakonarson (bib27) 2010; 38
Lindeman, Cagle, Beasley, Chitale, Dacic, Giaccone, Jenkins, Kwiatkowski, Saldivar, Squire, Thunnissen, Ladanyi (bib2) 2013; 15
van den Bent, Dubbink, Sanson, van der Lee-Haarloo, Hegi, Jeuken, Ibdaih, Brandes, Taphoorn, Frenay, Lacombe, Gorlia, Dinjens, Kros (bib22) 2009; 27
Frampton, Fichtenholtz, Otto, Wang, Downing, He (bib14) 2013; 31
Woehrer, Sander, Haberler, Kern, Maier, Preusser, Hartmann, Kros, Hainfellner (bib9) 2011; 30
Giardine, Riemer, Hardison, Burhans, Elnitski, Shah, Zhang, Blankenberg, Albert, Taylor, Miller, Kent, Nekrutenko (bib25) 2005; 15
van den Bent, Carpentier, Brandes, Sanson, Taphoorn, Bernsen, Frenay, Tijssen, Grisold, Sipos, Haaxma-Reiche, Kros, van Kouwenhoven, Vecht, Allgeier, Lacombe, Gorlia (bib19) 2006; 24
Reifenberger, Reifenberger, Liu, James, Wechsler, Collins (bib4) 1994; 145
Jeuken, Cornelissen, Boots-Sprenger, Gijsen, Wesseling (bib11) 2006; 8
Pritchard, Salipante, Koehler, Smith, Scroggins, Wood, Wu, Lee, Dintzis, Adey, Liu, Eaton, Martins, Stricker, Margolin, Hoffman, Churpek, Tait, King, Walsh (bib16) 2014; 16
Mensenkamp (10.1016/j.jmoldx.2016.06.002_bib28) 2014; 146
Pritchard (10.1016/j.jmoldx.2016.06.002_bib16) 2014; 16
Goecks (10.1016/j.jmoldx.2016.06.002_bib26) 2010; 11
Woehrer (10.1016/j.jmoldx.2016.06.002_bib9) 2011; 30
Geurts-Giele (10.1016/j.jmoldx.2016.06.002_bib24) 2014; 234
Boeva (10.1016/j.jmoldx.2016.06.002_bib15) 2014; 30
Harada (10.1016/j.jmoldx.2016.06.002_bib12) 2011; 13
Giardine (10.1016/j.jmoldx.2016.06.002_bib25) 2005; 15
van Lier (10.1016/j.jmoldx.2016.06.002_bib21) 2010; 14
Cairncross (10.1016/j.jmoldx.2016.06.002_bib7) 2006; 24
van den Bent (10.1016/j.jmoldx.2016.06.002_bib8) 2013; 31
Jeuken (10.1016/j.jmoldx.2016.06.002_bib11) 2006; 8
Vogazianou (10.1016/j.jmoldx.2016.06.002_bib6) 2010; 12
Piccart-Gebhart (10.1016/j.jmoldx.2016.06.002_bib3) 2005; 353
10.1016/j.jmoldx.2016.06.002_bib20
Dubbink (10.1016/j.jmoldx.2016.06.002_bib1) 2014; 8
Jenkins (10.1016/j.jmoldx.2016.06.002_bib5) 2006; 66
Wang (10.1016/j.jmoldx.2016.06.002_bib27) 2010; 38
Frampton (10.1016/j.jmoldx.2016.06.002_bib14) 2013; 31
van den Bent (10.1016/j.jmoldx.2016.06.002_bib22) 2009; 27
Hatanpaa (10.1016/j.jmoldx.2016.06.002_bib10) 2003; 83
Reifenberger (10.1016/j.jmoldx.2016.06.002_bib4) 1994; 145
Haraldsdottir (10.1016/j.jmoldx.2016.06.002_bib29) 2014; 147
Nikiforova (10.1016/j.jmoldx.2016.06.002_bib13) 2011; 135
van den Bent (10.1016/j.jmoldx.2016.06.002_bib19) 2006; 24
Cheng (10.1016/j.jmoldx.2016.06.002_bib18) 2015; 17
Lindeman (10.1016/j.jmoldx.2016.06.002_bib2) 2013; 15
Dubbink (10.1016/j.jmoldx.2016.06.002_bib23) 2016; 18
Grasso (10.1016/j.jmoldx.2016.06.002_bib17) 2015; 17
References_xml – volume: 145
  start-page: 1175
  year: 1994
  end-page: 1190
  ident: bib4
  article-title: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
  publication-title: Am J Pathol
– volume: 24
  start-page: 2707
  year: 2006
  end-page: 2714
  ident: bib7
  article-title: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
  publication-title: J Clin Oncol
– volume: 24
  start-page: 2715
  year: 2006
  end-page: 2722
  ident: bib19
  article-title: Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial
  publication-title: J Clin Oncol
– volume: 30
  start-page: 47
  year: 2011
  end-page: 55
  ident: bib9
  article-title: FISH-based detection of 1p 19q codeletion in oligodendroglial tumors: procedures and protocols for neuropathological practice - a publication under the auspices of the Research Committee of the European Confederation of Neuropathological Societies (Euro-CNS)
  publication-title: Clin Neuropathol
– volume: 17
  start-page: 251
  year: 2015
  end-page: 264
  ident: bib18
  article-title: Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology
  publication-title: J Mol Diagn
– volume: 16
  start-page: 56
  year: 2014
  end-page: 67
  ident: bib16
  article-title: Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens
  publication-title: J Mol Diagn
– volume: 66
  start-page: 9852
  year: 2006
  end-page: 9861
  ident: bib5
  article-title: A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
  publication-title: Cancer Res
– reference: Federation of Medical Scientific Societies: Human tissue and medical research: code of conduct for responsible use (2011). Available at
– volume: 8
  start-page: 830
  year: 2014
  end-page: 839
  ident: bib1
  article-title: Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe
  publication-title: Mol Oncol
– volume: 15
  start-page: 1451
  year: 2005
  end-page: 1455
  ident: bib25
  article-title: Galaxy: a platform for interactive large-scale genome analysis
  publication-title: Genome Res
– volume: 15
  start-page: 415
  year: 2013
  end-page: 453
  ident: bib2
  article-title: Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology
  publication-title: J Mol Diagn
– volume: 38
  start-page: e164
  year: 2010
  ident: bib27
  article-title: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
  publication-title: Nucleic Acids Res
– reference: (accessed July 25, 2016).
– volume: 8
  start-page: 433
  year: 2006
  end-page: 443
  ident: bib11
  article-title: Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors
  publication-title: J Mol Diagn
– volume: 18
  start-page: 388
  year: 2016
  end-page: 400
  ident: bib23
  article-title: Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial
  publication-title: Neuro Oncol
– volume: 12
  start-page: 664
  year: 2010
  end-page: 678
  ident: bib6
  article-title: Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses
  publication-title: Neuro Oncol
– volume: 11
  start-page: R86
  year: 2010
  ident: bib26
  article-title: Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences
  publication-title: Genome Biol
– volume: 30
  start-page: 3443
  year: 2014
  end-page: 3450
  ident: bib15
  article-title: Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data
  publication-title: Bioinformatics
– volume: 31
  start-page: 344
  year: 2013
  end-page: 350
  ident: bib8
  article-title: Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951
  publication-title: J Clin Oncol
– volume: 83
  start-page: 419
  year: 2003
  end-page: 428
  ident: bib10
  article-title: Molecular diagnosis of oligodendroglioma in paraffin sections
  publication-title: Lab Invest
– volume: 353
  start-page: 1659
  year: 2005
  end-page: 1672
  ident: bib3
  article-title: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
  publication-title: N Engl J Med
– volume: 234
  start-page: 548
  year: 2014
  end-page: 559
  ident: bib24
  article-title: Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers
  publication-title: J Pathol
– volume: 31
  start-page: 1023
  year: 2013
  end-page: 1031
  ident: bib14
  article-title: Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
  publication-title: Nat Biotechnol
– volume: 146
  start-page: 643
  year: 2014
  end-page: 646.e8
  ident: bib28
  article-title: Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors
  publication-title: Gastroenterology
– volume: 147
  start-page: 1308
  year: 2014
  end-page: 1316.e1
  ident: bib29
  article-title: Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations
  publication-title: Gastroenterology
– volume: 135
  start-page: 558
  year: 2011
  end-page: 568
  ident: bib13
  article-title: Molecular diagnostics of gliomas
  publication-title: Arch Pathol Lab Med
– volume: 17
  start-page: 53
  year: 2015
  end-page: 63
  ident: bib17
  article-title: Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data
  publication-title: J Mol Diagn
– volume: 14
  start-page: 181
  year: 2010
  end-page: 197
  ident: bib21
  article-title: A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
  publication-title: J Cell Mol Med
– volume: 27
  start-page: 5881
  year: 2009
  end-page: 5886
  ident: bib22
  article-title: MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951
  publication-title: J Clin Oncol
– volume: 13
  start-page: 541
  year: 2011
  end-page: 548
  ident: bib12
  article-title: Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis
  publication-title: J Mol Diagn
– volume: 66
  start-page: 9852
  year: 2006
  ident: 10.1016/j.jmoldx.2016.06.002_bib5
  article-title: A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-06-1796
– volume: 17
  start-page: 53
  year: 2015
  ident: 10.1016/j.jmoldx.2016.06.002_bib17
  article-title: Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data
  publication-title: J Mol Diagn
  doi: 10.1016/j.jmoldx.2014.09.008
– volume: 11
  start-page: R86
  year: 2010
  ident: 10.1016/j.jmoldx.2016.06.002_bib26
  article-title: Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences
  publication-title: Genome Biol
  doi: 10.1186/gb-2010-11-8-r86
– volume: 38
  start-page: e164
  year: 2010
  ident: 10.1016/j.jmoldx.2016.06.002_bib27
  article-title: ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkq603
– volume: 234
  start-page: 548
  year: 2014
  ident: 10.1016/j.jmoldx.2016.06.002_bib24
  article-title: Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers
  publication-title: J Pathol
  doi: 10.1002/path.4419
– volume: 15
  start-page: 1451
  year: 2005
  ident: 10.1016/j.jmoldx.2016.06.002_bib25
  article-title: Galaxy: a platform for interactive large-scale genome analysis
  publication-title: Genome Res
  doi: 10.1101/gr.4086505
– volume: 24
  start-page: 2715
  year: 2006
  ident: 10.1016/j.jmoldx.2016.06.002_bib19
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.04.6078
– volume: 147
  start-page: 1308
  year: 2014
  ident: 10.1016/j.jmoldx.2016.06.002_bib29
  article-title: Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2014.08.041
– volume: 18
  start-page: 388
  year: 2016
  ident: 10.1016/j.jmoldx.2016.06.002_bib23
  article-title: Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/nov182
– volume: 14
  start-page: 181
  year: 2010
  ident: 10.1016/j.jmoldx.2016.06.002_bib21
  article-title: A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory
  publication-title: J Cell Mol Med
  doi: 10.1111/j.1582-4934.2009.00977.x
– volume: 353
  start-page: 1659
  year: 2005
  ident: 10.1016/j.jmoldx.2016.06.002_bib3
  article-title: Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa052306
– volume: 145
  start-page: 1175
  year: 1994
  ident: 10.1016/j.jmoldx.2016.06.002_bib4
  article-title: Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
  publication-title: Am J Pathol
– volume: 24
  start-page: 2707
  year: 2006
  ident: 10.1016/j.jmoldx.2016.06.002_bib7
  article-title: Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2005.04.3414
– volume: 83
  start-page: 419
  year: 2003
  ident: 10.1016/j.jmoldx.2016.06.002_bib10
  article-title: Molecular diagnosis of oligodendroglioma in paraffin sections
  publication-title: Lab Invest
  doi: 10.1097/01.LAB.0000059948.67795.EF
– volume: 8
  start-page: 830
  year: 2014
  ident: 10.1016/j.jmoldx.2016.06.002_bib1
  article-title: Next generation diagnostic molecular pathology: critical appraisal of quality assurance in Europe
  publication-title: Mol Oncol
  doi: 10.1016/j.molonc.2014.03.004
– volume: 146
  start-page: 643
  year: 2014
  ident: 10.1016/j.jmoldx.2016.06.002_bib28
  article-title: Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2013.12.002
– volume: 31
  start-page: 344
  year: 2013
  ident: 10.1016/j.jmoldx.2016.06.002_bib8
  article-title: Adjuvant procarbazine, lomustine, and vincristine chemotherapy in newly diagnosed anaplastic oligodendroglioma: long-term follow-up of EORTC brain tumor group study 26951
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2012.43.2229
– volume: 16
  start-page: 56
  year: 2014
  ident: 10.1016/j.jmoldx.2016.06.002_bib16
  article-title: Validation and implementation of targeted capture and sequencing for the detection of actionable mutation, copy number variation, and gene rearrangement in clinical cancer specimens
  publication-title: J Mol Diagn
  doi: 10.1016/j.jmoldx.2013.08.004
– volume: 12
  start-page: 664
  year: 2010
  ident: 10.1016/j.jmoldx.2016.06.002_bib6
  article-title: Distinct patterns of 1p and 19q alterations identify subtypes of human gliomas that have different prognoses
  publication-title: Neuro Oncol
  doi: 10.1093/neuonc/nop075
– volume: 8
  start-page: 433
  year: 2006
  ident: 10.1016/j.jmoldx.2016.06.002_bib11
  article-title: Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors
  publication-title: J Mol Diagn
  doi: 10.2353/jmoldx.2006.060012
– volume: 13
  start-page: 541
  year: 2011
  ident: 10.1016/j.jmoldx.2016.06.002_bib12
  article-title: Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis
  publication-title: J Mol Diagn
  doi: 10.1016/j.jmoldx.2011.05.009
– volume: 135
  start-page: 558
  year: 2011
  ident: 10.1016/j.jmoldx.2016.06.002_bib13
  article-title: Molecular diagnostics of gliomas
  publication-title: Arch Pathol Lab Med
  doi: 10.5858/2010-0649-RAIR.1
– volume: 30
  start-page: 47
  year: 2011
  ident: 10.1016/j.jmoldx.2016.06.002_bib9
  publication-title: Clin Neuropathol
  doi: 10.5414/NPP30047
– volume: 31
  start-page: 1023
  year: 2013
  ident: 10.1016/j.jmoldx.2016.06.002_bib14
  article-title: Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
  publication-title: Nat Biotechnol
  doi: 10.1038/nbt.2696
– ident: 10.1016/j.jmoldx.2016.06.002_bib20
– volume: 30
  start-page: 3443
  year: 2014
  ident: 10.1016/j.jmoldx.2016.06.002_bib15
  article-title: Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btu436
– volume: 15
  start-page: 415
  year: 2013
  ident: 10.1016/j.jmoldx.2016.06.002_bib2
  publication-title: J Mol Diagn
  doi: 10.1016/j.jmoldx.2013.03.001
– volume: 17
  start-page: 251
  year: 2015
  ident: 10.1016/j.jmoldx.2016.06.002_bib18
  article-title: Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology
  publication-title: J Mol Diagn
  doi: 10.1016/j.jmoldx.2014.12.006
– volume: 27
  start-page: 5881
  year: 2009
  ident: 10.1016/j.jmoldx.2016.06.002_bib22
  article-title: MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2009.24.1034
SSID ssj0014462
Score 2.1256726
Snippet Cancer cells are genomically unstable and accumulate tumor type–specific molecular aberrations, which may represent hallmarks for predicting prognosis and...
SourceID crossref
elsevier
SourceType Enrichment Source
Index Database
Publisher
StartPage 775
SubjectTerms Pathology
Title Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing
URI https://www.clinicalkey.com/#!/content/1-s2.0-S1525157816300903
https://www.clinicalkey.es/playcontent/1-s2.0-S1525157816300903
https://dx.doi.org/10.1016/j.jmoldx.2016.06.002
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La8JAEF6sh9JL6ZPah-yh16CbTWJytFr7oHqxgrdlXwElJlIttP--s5uNWCwIPWYzQ8IwO4-db2YRuqeCRxpCBc9PpO8FUlOPg2P1aOpz43KklOYccjiKnifB6zSc1lCv6oUxsEpn-0ubbq21W2k5abaWs1lrbG7uIaBwxEyNSuzET9NVapr4pg-bSgKkO7biCcSeoa7a5yzGa74oMvVlAF6RneLpDld23NOWyxmcoGMXK-Ju-TunqKbzM3Q4dNXwczTulzg5eI37em1BVTkuUtzNMp3B4lthSrqY5wq_LIQBMYJVwOIbj0y-W06ctjzjElANbuwCTQaP771nz12S4Enqh5BIqjjSQtKEKJFAQuWHKlSB1qIDmV-kiGxTHsOmkwISiU4kIWKgieTwnkfmBJReonpe5PoKYRXE4DHTNCApDSJNYiCScaBpotqKp7SBaCUbJt0EcXORRcYqqNiclRJlRqLMIub8BvI2XMtygsYe-rASO6u6Q8GeMTDxe_g6f_HplduUK0bYymdttqM425y_dG_vN6__zXmDjsxTiVa7RfX1x6e-g_BmLZro4GlKmlaLfwCJOfls
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da8IwEA-ywbaXsU_mPvOw16Bt2to-Op3opr6o4FtIkxSU2sp0sP33uzSpOBwIe03uaDku95H73QWhZxrzQEGoQNxIuMQTihIOjpXQxOXa5Qgh9D3kYBh0J97b1J9WUKvshdGwSmv7jU0vrLVdqVlp1pazWW2kX-5xQOEcPTUq0hM_DyEaqGvV7k1fNqUEyHeKkidQE01e9s8VIK_5Ik_ll0Z4BcUYT3u7suOftnxO5wyd2mARN83_nKOKyi7Q0cCWwy_RqG2AcrCN22pdoKoynCe4maYqhcV-rmu6mGcS9xaxRjGCWcDxNx7qhNeMnC54RgZRDX7sCk06r-NWl9hXEoigrg-ZpAwDFQsaOTKOIKNyfelLT6m4AalfIB1RpzyEUydiyCQagYCQgUaCwz4P9BUovUYHWZ6pG4SlF4LLTBLPSagXKCcEIhF6ikayLnlCq4iWsmHCjhDXL1mkrMSKzZmRKNMSZQVkzq0isuFamhEae-j9UuysbA8Fg8bAxu_ha_zFp1b2VK6Yw1Yuq7Mdzdnm_KV8e795-2_OJ3TcHQ_6rN8bvt-hE71joGv36GD98akeINZZx4-FLv8AP7z7ng
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Diagnostic+Detection+of+Allelic+Losses+and+Imbalances+by+Next-Generation+Sequencing&rft.jtitle=The+Journal+of+molecular+diagnostics+%3A+JMD&rft.au=Dubbink%2C+Hendrikus+J.&rft.au=Atmodimedjo%2C+Peggy+N.&rft.au=van+Marion%2C+Ronald&rft.au=Krol%2C+Niels+M.G.&rft.date=2016-09-01&rft.pub=Elsevier+Inc&rft.issn=1525-1578&rft.volume=18&rft.issue=5&rft.spage=775&rft.epage=786&rft_id=info:doi/10.1016%2Fj.jmoldx.2016.06.002&rft.externalDocID=S1525157816300903
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F15251578%2FS1525157816X00050%2Fcov150h.gif